TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Reven Pharmaceuticals Stock

Reven Pharmaceuticals Stock

reven.comHealthcare / Other Healthcare

Reven Pharmaceuticals is a clinical-stage biopharmaceutical company that aims to treat metabolic and vascular diseases. With a mission to target the root cause of disease through innovative pursuits, Reven Pharmaceuticals uses its RJX platform to enhance medicines and improve patient outcomes. They also aim to treat diseases such as endothelial dysfunction, coronary artery disease, critical limb ischemia, and more. Reven Pharmaceuticals was founded by Brian Denomme and Peter Lange in 1999 and is headquartered in Denver, CO.

Buy or sell Reven Pharmaceuticals stockLearn more about Reven Pharmaceuticals IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Reven Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Reven Pharmaceuticals’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Reven Pharmaceuticals.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Peter Lange
Co - Founder & CEO
Brian Denomme
Co - Founder & President
Michael Volk
Co - Founder & CSO

Frequently Asked Questions About Reven Pharmaceuticals’ Stock

plusminus
Can you buy Reven Pharmaceuticals’ stock?
Reven Pharmaceuticals is not publicly traded on NYSE or NASDAQ in the U.S. To buy Reven Pharmaceuticals’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Reven Pharmaceuticals’ stock?
Yes, you can sell stock of a private company like Reven Pharmaceuticals. Forge can help you sell your Reven Pharmaceuticals stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Reven Pharmaceuticals’ stock price?
Reven Pharmaceuticals is a privately held company and therefore does not have a public stock price. However, you may access Reven Pharmaceuticals’ private market stock price with Forge Data.
plusminus
What is Reven Pharmaceuticals’ stock ticker symbol?
Reven Pharmaceuticals does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Reven Pharmaceuticals in the Other Healthcare sector

Phil

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$300.91MM

Insightec

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$500MM

Blink Health

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$1.26B

Selkirk Pharma

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.45B

Zephyr AI

Sector
Healthcare / Other Healthcare
 
 

Parallel

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.47B

Nutrafol

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$150MM

Lumicell

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$315.94MM

Nimble Rx

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$115MM

Trending Companies

Frequently Asked Questions

Updated on: Apr 27, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.